2018
DOI: 10.1016/j.lfs.2018.07.055
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological evaluation of novel PKR inhibitor indirubin-3-hydrazone in-vitro in cardiac myocytes and in-vivo in wistar rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 31 publications
0
8
0
Order By: Relevance
“…Apart from imoxin and 2-aminopurine, indirubin-3-oxime, a derivative of indirubin has been reported as novel PKR inhibitor 14 . Previously, our lab reported the effect of a newly synthesized derivative of indirubin, indirubin-3-hydrazone on high glucose induced apoptosis and oxidative stress 15 . However, the effect of PKR inhibitors on insulin resistance in skeletal muscle, liver and the relationship between PKR and pancreatic β-cell mass has not been reported yet.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Apart from imoxin and 2-aminopurine, indirubin-3-oxime, a derivative of indirubin has been reported as novel PKR inhibitor 14 . Previously, our lab reported the effect of a newly synthesized derivative of indirubin, indirubin-3-hydrazone on high glucose induced apoptosis and oxidative stress 15 . However, the effect of PKR inhibitors on insulin resistance in skeletal muscle, liver and the relationship between PKR and pancreatic β-cell mass has not been reported yet.…”
Section: Discussionmentioning
confidence: 99%
“…To develop diabetic animal model, hyperglycemia was induced by feeding rats with 20% high fructose water, followed by induction of late onset of type 2 diabetes by administering low dose of STZ as described previously 15 , 16 . Study animals were divided into four groups.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations